Michael A Moskowitz

Michael A. Moskowitz, MD is a Full Professor in the Department of Neurology at Harvard Medical School, where he leads a highly influential research program with over 628 publications and 88,588 citations. His laboratory focuses on the neurobiological mechanisms underlying migraine, stroke, and neurovascular interactions, with particular emphasis on cortical spreading depression as the electrophysiological correlate of migraine aura.

Dr. Moskowitz's research interests span neurovascular biology, migraine pathophysiology, cortical spreading depression mechanisms, trigeminovascular system function, and neuroimmune communication through skull-bone marrow channels. His lab pioneered the trigeminovascular theory of migraine in 1979, fundamentally transforming our understanding of migraine from a vascular disorder to a neurovascular pain condition.

Analysis of his recent publications (2022-2025) reveals three dominant research trajectories: 1) Groundbreaking work using intravital three-photon microscopy to map skull-bone marrow channels as immune gateways to the CNS, 2) Continued refinement of migraine pathophysiology with emphasis on cortical spreading depression's role in headache generation, and 3) Investigation of neuroimmune mechanisms connecting peripheral inflammation to central nervous system disorders including depression and stroke.

His scientific impact is evidenced by numerous highly-cited publications including seminal works on the trigeminovascular system, cortical spreading depression, and migraine-stroke connections. His research has established foundational concepts that directly informed the development of modern migraine therapeutics including triptans and CGRP-targeted medications.

Dr. Moskowitz maintains an exceptionally active research program with consistent high-impact publications, currently supervising multiple postdoctoral fellows and collaborating with leading institutions worldwide. His laboratory employs advanced techniques including intravital microscopy, electrophysiology, and molecular approaches to investigate neurovascular and neuroimmune mechanisms. The lab's recent discoveries regarding skull-bone marrow communication channels represent a paradigm shift in understanding neuroimmune interactions.

His laboratory's research on calvarial bone marrow channels and neuroimmune crosstalk has created new avenues for understanding migraine, stroke recovery, and depression pathophysiology. The team's innovative use of three-photon microscopy to visualize deep-tissue interactions between the skull, bone marrow, and meninges has opened a new field of cranial immunology with implications across neurological disorders.